Title : Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.

Pub. Date : 2020 Apr 17

PMID : 32167144






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A direct podocyte effect seems to contribute to the beneficial effect of NDP-MSH, because Adriamycin-inflicted cytopathic signs in primary podocytes prepared from WT mice were all mitigated by NDP-MSH, including apoptosis, loss of podocyte markers, de novo expression of the podocyte injury marker desmin, actin cytoskeleton derangement and podocyte hypermotility. Doxorubicin Norrie disease (pseudoglioma) (human) Mus musculus